Inventor · disambiguated record
Travis L. Houston
Also filed as: HOUSTON TRAVIS · HOUSTON TRAVIS L · HOUSTON TRAVIS LEE
26 granted patents·17 pending applications·148 citations·filing 2007–2025
95Inventor score
Files withGLOBAL BLOOD THERAPEUTICS INC9GILEAD SCIENCES INC4VITAE PHARMACEUTICALS LLC4GUSHURST KAREN S3INCYTE CORP3
Top patents by PatentIndex Score
43 records- 0198US9447071B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·36 cites·33 claims
- 0297US11266638B2Choline salt forms of an HIV capsid inhibitorGILEAD SCIENCES INC·Filed 2020·Granted Mar 8, 2022·7 cites·23 claims
- 0397US10137118B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Nov 27, 2018·20 cites·6 claims
- 0496US11833143B2Choline salt forms of an HIV capsid inhibitorGILEAD SCIENCES INC·Filed 2022·Granted Dec 5, 2023·3 cites·28 claims
- 0596US10849892B2Choline salt forms of an HIV capsid inhibitorGILEAD SCIENCES INC·Filed 2018·Granted Dec 1, 2020·22 cites·22 claims
- 0695US11479557B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Oct 25, 2022·4 cites·23 claims
- 0793US8067429B2Forms of rifaximin and uses thereofGUSHURST KAREN S·Filed 2009·Granted Nov 29, 2011·23 cites·23 claims
- 0891US12312359B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2022·Granted May 27, 2025·1 cites·15 claims
- 0991US10683302B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Jun 16, 2020·9 cites·28 claims
- 1088US2025032471A1Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1187US11452720B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·1 cites·14 claims
- 1285US8754098B2Forms of rifaximin and uses thereofGUSHURST KAREN S·Filed 2012·Granted Jun 17, 2014·5 cites·22 claims
- 1384US10722502B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·1 cites·3 claims
- 1483US8513275B2Forms of rifaximin and uses thereofWU YIDUO·Filed 2011·Granted Aug 20, 2013·8 cites·6 claims
- 1583US2024245669A1Choline Salt Forms of an HIV Capsid InhibitorGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 1682US8815888B2Forms of rifaximin and uses thereofWU YIDUO·Filed 2013·Granted Aug 26, 2014·6 cites·20 claims
- 1782US2022395492A1Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1881US12358873B2Crystalline salts of psilocinCANNA CHEMISTRIES LLC·Filed 2024·Granted Jul 15, 2025·0 cites·19 claims
- 1981US2025270221A1Solid forms of jak inhibitor and process of preparing the sameINCYTE CORP·Filed 2025·Application pending·0 cites
- 2078US2025026760A1Solid forms of jak inhibitor and process of preparing the sameINCYTE CORP·Filed 2024·Application pending·0 cites
- 2178US2025326764A1Inhibitors of the menin-mll interactionVITAE PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
- 2276US12473277B2Solid forms of a modulator of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2023·Granted Nov 18, 2025·0 cites·22 claims
- 2374US9211290B2Solid dispersions of amorphous paroxetine mesylateNOVEN THERAPEUTICS LLC·Filed 2013·Granted Dec 15, 2015·1 cites·6 claims
- 2473US2023399331A1Solid forms of jak inhibitor and process of preparing the sameINCYTE CORP·Filed 2023·Application pending·0 cites
- 2571US11851424B2Solid forms of a modulator of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Granted Dec 26, 2023·0 cites·19 claims
- 2671US8906948B2Choline cocrystal of epalrestatKALOFONOS ISABEL·Filed 2009·Granted Dec 9, 2014·1 cites·20 claims
- 2767US2016346263A1Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2863US2025073244A1Crystalline forms of pentaaza macrocyclic ring complexGALERA LABS LLC·Filed 2024·Application pending·0 cites
- 2962US2025388550A1Salts of an antioxidant and crystalline forms thereofTrampota Jan·Filed 2023·Application pending·0 cites
- 3057US2012076857A1Forms of rifaximin and uses thereofGUSHURST KAREN S·Filed 2011·Application pending·0 cites
- 3156US9611234B2Choline cocrystal of epalrestatBIONEVIA LLC·Filed 2014·Granted Apr 4, 2017·0 cites·10 claims
- 3256US2022371994A1Crystalline polymorphic form of psilocinCANNA CHEMISTRIES LLC·Filed 2022·Application pending·0 cites
- 3355US2023279021A1Polymorphs of a gabaa alpha5 agonist and methods of using in the treatment of cognitive impairmentAGENEBIO INC·Filed 2021·Application pending·0 cites
- 3454US12351588B2Salt forms and solvates of Mcl-1 antagonistsAMGEN INC·Filed 2023·Granted Jul 8, 2025·0 cites·17 claims
- 3553US11173156B2Solid forms of a kynurenine-3-monooxygenase inhibitorCHDI FOUNDATION INC·Filed 2020·Granted Nov 16, 2021·0 cites·10 claims
- 3653US10464912B2Choline cocrystal of epalrestatBIONEVIA PHARMACEUTICALS INC·Filed 2017·Granted Nov 5, 2019·0 cites·16 claims
- 3752US9447056B2Solid forms of epalrestatBIONEVIA PHARMACEUTICALS INC·Filed 2014·Granted Sep 20, 2016·0 cites·6 claims
- 3852US2023365618A1Crystalline thiocholesterolDURECT CORP·Filed 2021·Application pending·0 cites
- 3950US8697735B2Solid forms of epalrestatKALOFONOS ISABEL·Filed 2011·Granted Apr 15, 2014·0 cites·21 claims
- 4050US2023056273A1Crystalline and liquid crystalline 25-hydroxy-cholest-5-en-3-sulfate sodium and methods for preparing sameDURECT CORP·Filed 2020·Application pending·0 cites
- 4149US12459890B2Salt and crystal form of compound having agonistic activity to S1P5 receptorONO PHARMACEUTICAL CO·Filed 2020·Granted Nov 4, 2025·0 cites·34 claims
- 4247US2010062046A1Polymorphs of nicotinic intermediatesALLEN DOUGLAS J M·Filed 2007·Application pending·0 cites
- 4346US2016136148A1Solid dispersions of amorphous paroxetine mesylateNOVEN THERAPEUTICS LLC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →